TY - CHAP M1 - Book, Section TI - Chapter 316. Measles A1 - Moss, William J. A1 - Katz, Samuel L. A2 - Rudolph, Colin D. A2 - Rudolph, Abraham M. A2 - Lister, George E. A2 - First, Lewis R. A2 - Gershon, Anne A. PY - 2011 T2 - Rudolph's Pediatrics, 22e AB - Measles virus infection is one of the most important infectious diseases of humans and has caused millions of deaths since its emergence as a zoonosis thousands of years ago. Prior to the development and widespread use of measles vaccines, measles was estimated to cause between 5 and 8 million deaths worldwide each year. Remarkable progress in reducing measles incidence and mortality has been made, particularly in sub-Saharan Africa,1,2 as a consequence of increasing routine measles vaccine coverage and provision of a second opportunity for measles vaccination through mass measles vaccination campaigns (called supplementary immunization activities [SIAs]).3 In the Americas, intensive immunization and surveillance efforts have stopped endemic transmission of measles virus, in part based on the successful Pan American Health Organization strategy of nationwide measles vaccination campaigns and high routine measles vaccine coverage.4 In the United States, high coverage with two doses of measles vaccine has eliminated endemic measles virus transmission. These achievements attest to the enormous public health significance of measles vaccination. SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/28 UR - accesspediatrics.mhmedical.com/content.aspx?aid=7030385 ER -